Nitric oxide inhibits vascular bioactivation of glyceryl trinitrate: A novel mechanism to explain preferential venodilation of organic nitrates

Molecular Pharmacology

Volumn 53, Issue 3, 1998, Pages 547-554

  Kojda, Georg ^a   Patzner, Markus ^a   Hacker, Andreas ^a   Noack, Eike ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL 1,2 DINITRATE; GLYCEROL 1,3 DINITRATE; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; NITRIC OXIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DRUG INHIBITION; FEMALE; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SWINE; THROMBOCYTE; VASODILATATION;

EID: 0031977184     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.3.547     Document Type: Article

References (40)

1. Ahlner J, Andersson RGG, Torfgård K, and Axelsson KL (1991) Organic nitrate esters: clinical use and mechanisms of actions. Pharmacol Rev 43:351-423.
2. Alheid U, Dudel C, and Förstermann U (1987) Selective inhibition by gossypol of endothelium-dependent relaxations augments relaxations to glyceryl trinitrate. Br J Pharmacol 92:327-240.
3. Armstrong PW, Walker DC, Burton JR, and Parker JO (1975) Vasodilator therapy in acute myocardial infarction: a comparison of sodium nitroprusside and nitroglycerin. Circulation 52:1118-1122.
4. Axelsson KL and Andersson RGG (1983) Tolerance towards glyceryl trinitrate, induced in vivo, is correlated to a reduced cGMP-response and an alteration in cGMP-turnover. Eur J Pharmacol 88:71-79.
5. Barnett DJ, McAninly J, and Williams DLH (1994) Transnitrosation between nitrosothiols and thiols. J Chem Soc Perkin Trans 2:1131-1133.
6. Bassenge E and Stuart DJ (1986) Effects of nitrates in various vascular sections and regions. Z Kardiol 75(Suppl 3):1-7.
7. Bates JN, Baker MT, Guerra R Jr, and Harrison DG (1991) Nitric oxide generation from nitroprusside by vascular tissue: evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol 42(suppl):S157-S165.
8. Beckman JS and Crow JP (1993) Pathological implications of nitric oxide, Superoxide and peroxynitrite formation. Biochem Soc Trans 21:330-334.
9. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
10. Brien JF, McLaughlin BE, Breedon TH, Bennett BM, Nakatsu K, and Marks GS (1986) Biotransformation of GTN occurs concurrently with relaxation of rabbit aorta. J Pharmacol Exp Ther 237:608-614.
11. Chung SJ and Fung HL (1990) Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells. J Pharmacol Exp Ther 253:614-619.
12. Cocks TM and Angus JA (1983) Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature (Lond) 305:627-630.
13. Collins P, Griffith TM, Hendersson AH, and Lewis MJ (1986) Endothelium-derived relaxing factor alters calcium fluxes in rabbit aorta: a cyclic guanosine monophosphate-mediated effect. J Physiol (Lond) 381:427-437.
14. De Mey JG and Vanhoutte PM (1982) Heterogeneous behavior of the canine arterial and venous wall: importance of the endothelium. Circ Res 51:439-447.
15. + as the effective reagent in nitric oxide formation from Snitrosothiols (RSNO). J Chem Soc Perkin Trans 2:481-487.
16. Feelisch M and Noack E (1987) Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Phar-macol 139:19-30.
17. Field L, Dilts RV, Ravichandran R, Lenhert G, and Carnahan GE (1978) An unusual stable thionitrite from N-acetyl-D,L-penicillamine: x-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethyl thionitrite. JCS Chem Commun 1157:249-250.
18. Fung H-L, Sutton SC, and Kamiya A (1984) Blood vessel uptake and metabolism of organic nitrates in the rat. J Pharmacol Exp Ther 228:334-341.
19. Goldberg ND and Haddox MK (1977) Cyclic GMP metabolism and involvement in biological regulation. Annu Rev Biochem 46:823-896.
20. 2: a pulse radiolysis study. Free Radic Biol Med 19:505-510.
21. Hafner D, Keinen E, and Noack E (1977) Mathematical analysis of concentration-response relationships. Arzneim Forsch 27:1871-1873.
22. Keefer LK, Nims RW, Davies KM, and Wink DA (1996) 'NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 268:281-293.
23. Kojda G, Klaus W, Werner G, and Fricke U (1991) The influence of 3-ester side chain variation on the cardiovascular profile of nitrendipine in porcine isolated trabeculae and coronary arteries. Naunyn-Schmiedeberg's Arch Pharmacol 344:488-494.
24. Kojda G, Beck JK, Meyer W, and Noack E (1994) Nitrovasodilator-induced relaxation and tolerance development in porcine vena cordis magna: dependence on intact endothelium. Br J Pharmacol 112:533-540.
25. Kojda G, Kottenberg K, Nix P, Schlüter KD, Piper HM, and Noack E (1996) Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78:91-101.
26. Kojda G, Laursen JB, Ramasamy S, Kent JD, Kurz S, Shesely EG, Smithies O, and Harrison DG (1997) Disruption of the eNOS gene causes hypersensitivity of mouse aorta to vasoconstrictors and glyceryl trinitrate. Naunyn-Schmiedeberg's Arch Pharmacol 355:R41.
27. Kojda G and Noack E (1993) Nitric oxide liberating, soluble guanylate cyclase stimulating and vasorelaxing properties of SPM 3672. J Cardiovasc Pharmacol 22:103-111.
28. Kowaluk EA, Seth P, and Fung H-L (1992) Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 262:916-922.
29. Kowaluk EA and Fung H-L (1990) Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther 255:1256-1264.
30. Lang D and Lewis MJ (1989) Endothelium-derived relaxing factor inhibits the formation of inositol triphosphate by rabbit aorta. J Physiol (Lond) 411:45-52.
31. Lüscher TF, Diedrich D, Siebenmann R, Lehmann K, and Stülz P (1988) Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 319:462-467.
32. Moncada S, Rees DD, Schulz R, and Palmer RMJ (1991) Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 88:2166-2170.
33. Mülsch A, Mordvintcev P, Bassenge E, Jung F, Clement B, and Busse R (1995) In vivo spin trapping of glyceryl trinitrate-derived nitric oxide in rabbit blood vessels and organs. Circulation 92:1876-1882.
34. Pfitzer G, Hoftman F, Disalvo J, and Ruegg JC (1984) cGMP and cAMP inhibit tension development in skinned coronary arteries. Pflueg Arch Eur J Physiol 401:277-280.
35. Pohl U, Holtz J, Busse R, and Bassenge E (1986) Crucial role of endothelium in the vascular response to increased flow in vivo. Hypertension (Dallas) 8:37-44.
36. Schröder H and Schrör K (1990) Inhibitors of cytochrome P-450 reduce cGMP stimulation by glyceryl trinitrate in LLC-PK1 Kidney epithelial cells. Naunyn-Schmiedeberg's Arch Pharmacol 342:616-618.
37. Schultz G and Böhme E (1984) Guanylate cyclase, in Methods of Enzymatic Analysis (Bergmeyer HU, ed) pp 379-389, Verlag Chemie, Weinheim, Germany.
38. Sekhar KR, Hatchett RJ, Shabb JB, Wolfe L, Francis SH, Wells JM, Jastorff B, Butt E, Chakimala MM, and Corbin JD (1992) Relaxation of pig coronary arteries by new and potent cGMP analogs that selectively activate type Iα, compared with type Iβ, cGMP-dependent protein kinase. Mol Pharmacol 42:103-108.
39. Twort CHC and van Breemen C (1988) Cyclic guanosine monophosphate enhanced sequestration of calcium by sarcoplasmatic reticulum in vascular smooth muscle. Circ Res 62:961-964.
40. Zhang CL, De la Lande IS, Stafford I, and Horowitz JD (1994) S-Nitrosothiol modulation of tolerance to glyceryl trinitrate in bovine isolated coronary artery. Eur J Pharmacol 252:299-304.